Jonathan Emberson

Professor of Medical Statistics and Epidemiology

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jonathan Emberson is a Professor of Medical Statistics and Epidemiology at the University of Oxford, UK. His research areas include the long-term effectiveness of medical therapies, the epidemiology of chronic diseases, and health outcomes related to pharmacological interventions. Recent articles have explored topics such as the cost-effectiveness of statin therapy, the impact of empagliflozin on kidney disease, and the relationship between diet and cardiometabolic health.

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (41)

William Ricketts

Honorary Senior Lecturer

Queen Mary University of London

UNITED KINGDOM

Jonathan Emberson

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic disease

Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study

A deep catalogue of protein-coding variation in 983,578 individuals.

Associations of fruit intake with adiposity and cardiometabolic biomarkers in UK Biobank

Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets

Alcohol and mortality in Mexico: prospective study of 150 000 adults.

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.

Effect of Fenofibrate on Progression of Diabetic Retinopathy.

2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG

2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG

Body mass index and COVID-19 mortality: prospective study of 120 000 Mexican adults.

Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic Epidemiology

Human genetics uncovers <i>MAP3K15</i> as an obesity-independent therapeutic target for diabetes.

Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19

Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial.

Allocated but not treated: the silent 16% - Authors' reply.

Collaborators (41)

William Ricketts

Chee Kay Cheung

Hugh Welch

Vishal Dey

David Preiss

John Robson

Lisa Holland

Fiona Bragg

Stephen E. Fremes

Nazia Chaudhuri

Colin Baigent

Jennifer Logue

Christopher Green

Lyrics Noba

Roxana Mehran

Federico Murgia

Ryan Dhindsa

Adilia Warris

Beatriz Duran Jimenez

David Allsup

Geeshath Jayasekera

Ankur Gupta-Wright

Maheshi N Ramasamy

Eric Gamazon

Salman Razvi

Shaman Jhanji

John J V McMurray

Kaitlin Mayne

Brian W Johnston

Xin Hui Chan

Richard Haynes

Miriam Thake

Jennifer Carter

Anil Hormis

Joseph Lewis

Louisa Gnatiuc Friedrichs

Anthony Yong Kheng Cordero Ng

William Herrington

Xavier Rossello

Tom Dymond

Borislava Mihaylova

Make your next move.